The device could upend treatment for the 33 million to 45 million Americans with severe allergies to food and other triggers.

FDA officials say this is the first epinephrine product for anaphylaxis that is not administered with a needle.

Last week the FDA approved Neffy, an epinephrine nasal spray, for use in emergency allergic reactions for kids and adults. Retired allergist at the Northwest Asthma & Allergy Center Paul Williams said ...

The FDA has approved a nasal spray, called neffy, to treat serious allergic reactions in adults and children who weigh at ...

A nasal spray developed ... Research shows the spray, recently approved in the EU and US, is just as effective at stopping ...

Whether it’s allergies, a sinus infection or runny nose … many people turn to nasal sprays for quick relief. And now, there’s growing interest in other nasal spray products … such as vaccines, and ...

ARS Pharmaceuticals' neffy, a needle-free nasal spray for allergies, receives FDA approval, driving stock price up 120%. Read ...

The FDA recently approved the first needle-free epinephrine product (neffy), an alternative to injectable epinephrine (EpiPen ...

The US Food and Drug Administration (FDA) has approved the targeted interleukin (IL)-13 inhibitor lebrikizumab (Ebglyss) for ...

The FDA approved lebrikizumab (Ebglyss) for treating atopic dermatitis in adults and children ages 12 years and up, drugmaker ...

ARS Pharmaceuticals Inc. submitted a supplemental New Drug Application (sNDA) for a1 mg dose of nasal spray neffy, to treat ...